NNECOS Patient Assistance Presentation Series!
NNECOS is excited to launch our virtual NNECOS Patient Assistance Presentation Series. Previously offered in conjunction with the NNECOS Spring Meeting, this virtual series will provide an opportunity for invited corporate member companies to showcase their patient assistance programs to financial advocates, social workers, navigators, and other interested members of the care team in the NNECOS community. Practice/clinic participants have the opportunity to sign-up for NNECOS-sponsored lunch!
Session Dates:
Sessions will be held from 12:00 - 1:00 pm, with lunch provided by NNECOS
Thursday, June 2nd - Sanofi, BeiGene, Bayer, Rigel, AstraZeneca, Merck, Pfizer
Thursday, August 4th - Janssen, BMS, Guardant Health, Pharmacyclics, Ipsen, Lilly, Genentech
Thursday, October 6th - Epizyme, Amgen, Astellas, Takeda, Coherus
RESCHEDULED: date TBD - Jazz Pharmaceuticals, Seagen, Exelixis, Eisai, Incyte, Astellas, Servier
Companies listed below are contacted on a quarterly basis to review their listing and provide any updates.
Last updated 9/4/2022
Abbvie |
GlaxoSmithKline |
Adaptive Biotechnologies Karuna Craig Patient Access and Reimbursement Manager kcraig@adaptivebiotech.com Patient Hotline (855) 236 9230 Clinical Services (888) 552-8988 https://www.clonoseq.com/adaptive-assist |
Guardant Health Joana Buxhaku Account Executive, Boston North – MA, NH, ME, VT Mobile +1 781 219 8511 Email: clientservices@guardanthealth.com |
Agios Pharmaceuticals Elisabeth Herdic, RN, CCM, PACS Patient Support Manager MyAgios 1-800-951-3889 My Agios Patient Services |
Heron Therapeutics CINVANTI® (aprepitant) injectable emulsion |
Alexion Jen Ulven Field Reimbursement Manager 1-904-874-3344 |
Incyte Maura (Eichman) Sandell, BSN Oncology Therapeutic Specialist Incyte Corporation 1801 Augustine Cut-offWilmington, DE 19803 603-718-9295 Monjuvi Jakafi My Mission Support (for Monjuvi) |
AMAG Pharmaceuticals
Feraheme Assist Feraheme IV Iron Mariaelena Galie Senior Manager, Patient Services 267-275-1185 |
Ipsen Somatuline Depot(Lanreotide), and Onivyde(Irinotecan Liposome Injection) Patient Access services: www.ipsencares.com |
Amgen Field Reimbursement Specialist 781-815-2694 |
Janssen Janssen CompassTM support program dedicated to patients who have been prescribed either ERLEADA® (apalutamide), DARZALEX® (daratumumab), or DARZALEX Faspro® (daratumumab and hyaluronidase-fihj) https://www.janssencompass.com |
Astellas |
Jazz Pharmaceuticals |
AstraZeneca/MedImmune Jenifer N. McNulty Joann Dousa, RPh, AE-C Field Reimbursement Manager, Oncology Connecticut, Upstate New York, Northwestern PA Cell: 508-813-2834 Joann.Dousa@astrazeneca.com |
Karyopharm Therapeutics Jacqueline Buckley Corporate Account Director 85 Wells Avenue Suite 210 Newton MA 02459 Cell: 774- 236-0231 jbuckley@karyopharm.com XPOVIO® (selinexor) For HCPs: www.XPOVIOpro.com https://www.karyforward.com |
Aveo Oncology Caroline Ward, RN, BSN Oncology Account Manager-New England cward@aveooncology.com 603-707-6223 Product: Fotivda (tivozanib) AVEO ACE Program- Access Center of Excellence www.fotivda.com to enroll 1-833-Fotivda (1-833-368-4832) |
Lilly USA Verzenio.com 1-844-verzenio (1-844-837-9364) Lilly Cares Foundation Lillycares.com 1-800-545-6962 |
Bayer Xofigo Patient Assistance Vitrakvi Patient Assistance |
Merck Mark Montello |
BeiGene |
Novartis Oncology Elizabeth Gugliotta Associate Director Access & Reimbursement Elizabeth.Gugliotta@novartis.com Cell: 401-480-9905 https://copay.novartisoncology.com |
Blueprint Medicines Fred Richards Key Account Manager – New England Blueprint Medicines 781-258-1457 frichards@blueprintmedicines.com |
|
BMS Access Support Manager, Access & Reimbursement Manager Oncology Hematology |
Oncopeptides PEPAXTO (melphalan flufenamide) |
Boehringer-Ingelheim Cathy Berry For more information on the BI Cares Foundation, call 1-855-297-5906 or visit www.boehringer-ingelheim.us/our-responsibility/patient-assistance-program |
Pharmacyclics Field Access Specialist – Northeast Cell: 603-777-6362 Email: Jason.hart@abbvie.com IMBRUVICA (ibrutinib) Patient Access & Support Services: www.imbruvicabyyourside.com |
Clovis Oncology Katheryne Murray Cell: 860-876-5568 Rubraca® (rucaparib) |
Pfizer Field Reimbursement Manager Pfizer Patient Assistance: Ibrance, Talzenna, Xalkori, Lorbrena, Inlyta, Torisel, Vizimpro, Bosulif, Sutent, Daurismo, Besponsa, Mylotarg, Retacrit, Nyvestim, Nyvepria, Bavencio, Braftovi-Mektovi, Ruxience, Trazimera, Zirabev |
Coherus Biosciences, Inc. |
Puma Biotechnology Daniel Coffey |
Daiichi Sankyo Jill Coyle, MBA, BSN, RN Senior Oncology Territory Manager Oncology Breast 211 Mount Airy Road Basking Ridge, NJ 07920 Mobile +207-272-2598 icoyle@dsi.com Products: Injectafer, Enhertu and Turaliohttps://dsiaccesscentral.com/ |
Regeneron |
Dova Pharmaceuticals Richard DeBone |
Rigel Pharmaceuticals Kent Main |
Eisai Meghan Walsh Senior Manager, Access & Reimbursement 508-397-0718 Lenvima and Halaven Eisai Assistance Program For program and eligibility information, and to review the program terms and conditions, please visit eisaireimbursement.com or call 1-866-61-EISAI (1-866-613-4724) |
Sandoz Biopharmaceuticals |
EMD Serono Walter Serafin, MA, BA Associate Director, Field Patient Services - Oncology EMD Serono, Inc. Mobile: (339) 214-6080 Office: (913) 322-6063 One Technology Place For Bavencio: CoverOne.com Phone: (844) Cover1 or (844) 826-8371 Monday-Friday: 8:00am-8:00pm ET
For Tepmetko: OncNavigationCenter.com Phone: 1-844-662-3631 (844-ONC-EMD1) Monday–Friday: 8:00 am–8:00 pm ET |
Sanofi Sarclisa (isatuximab-irfc), Jevtana (Cabazitaxel), Elitek (Raspuricase) |
Epizyme Scott Obenshain, MBA Associate Director of Epigenetic Therapy sobenshain@epizyme.com (716) 998-5662(cell) TAZVERIK™ (tazemetostat) EpizymeNOW or 1-833-4EPINOW (437-4669) |
Seagen Michelle L. Vallee Senior Oncology Account Manager (207)229-6702 855.4SECURE (855.473.2873), Option 1ADCETRIS® (brentuximab vedotin) PADCEV™ (enfortumab vedotin-ejfv) (See Astellas) TUKYSA®(tucatinib) Tivdak™ (tisotumab vedotin-tftv) |
Exelixis Michele Sofarelli Luther Associate Director, Patient Access CABOMETYX.com |
Servier For help with access and financial assistance, call 800-813-5905 or visit ServierOne.com. |
Sobi Kara Olenio – Health System Director Kara.Olenio@sobi.com 603-843-7336 Gamifant® (emapalumab-lzsg)For Caregivers & Patients (gamifantcares.com) |
|
Genentech Cell: 475-254-6532 E-mail: Villarreal.Paul@gene.com Infused Products: AVASTIN® (bevacizumab) , GAZYVA® (obinutuzumab)HERCEPTIN® (trastuzumab), KADCYLA® (ado-trastuzumab emtansine), PERJETA® (pertuzumab), POLIVY™ (POLATUZUMAB VEDOTIN-PIIQ), RITUXAN® (rituximab), TECENTRIQ® (atezolizumab) Subcutaneous Products: HERCEPTIN HYLECTA™ (TRASTUZUMAB AND HYALURONIDASE-OYSK), PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf), RITUXAN HYCELA™ (rituximab/hyaluronidase human) |
Stemline Therapeutics Taiho Oncology Bob Stewart |
Genomic Health
Dan Monteith |
Deborah Looney Field Access Director Ph: 617-543-9736 deborah.looney@takeda.com Takeda Oncology Here2Assist™ |
Gilead Melissa McLean 1-844-454-5483 TRODELVY |
Teva Pharmaceutical Industries Ltd. Kate Friday Kate.Friday@tevapharm.com US ACT Parsippany, NJ |
TG Therapeutics Kelly Bucklen 401.261.5262 Ukoniq (Umbralisib) |
Other Specialty Contacts
Acredo Specialty Pharmacy Jeremy Boehm
Sr. Account Director
Accredo Specialty Pharmacy
M: 781-980-2179
F: 855-817-2712
jboehm@express-scripts.com
Diplomat Specialty Pharmacy
Yakini Brown
Pharmacy Liaison
P. 810.768.9115
F. 810.262.0261
ybrown@diplomat.is
Foundation Medicine
Bill Walsh
Senior Account Executive | New England
C: 603.391.8174
Client Services: 888.988.3639
Foundation Medicine, Inc.
150 Second Street, Cambridge, MA 02141
bwalsh@foundationmedicine.comKroger Specialty Pharmacy
Kevin B. Penner
Oncology Specialty Account Manager- New England
Phone: 860-227-3458
Fax: 888-315-3270
kevin.penner@krogerhealth.com
www.krogerspecialtypharmacy.com